1. Home
  2. SILO vs INBS Comparison

SILO vs INBS Comparison

Compare SILO & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.44

Market Cap

7.2M

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.57

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SILO
INBS
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
5.7M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
SILO
INBS
Price
$0.44
$2.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.6M
75.3K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
57.98
68.65
EPS
N/A
N/A
Revenue
$72,102.00
$1,980,484.00
Revenue This Year
$1.86
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.54
52 Week High
$1.13
$24.90

Technical Indicators

Market Signals
Indicator
SILO
INBS
Relative Strength Index (RSI) 48.09 36.74
Support Level $0.29 $2.42
Resistance Level $0.43 $7.25
Average True Range (ATR) 0.08 0.23
MACD -0.00 0.07
Stochastic Oscillator 13.62 25.68

Price Performance

Historical Comparison
SILO
INBS

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: